title: Why do drugs work in CLL?
authors.affiliation: University of Texas MD Anderson Cancer Center, Houston 77030, USA.
authors.forename: W
authors.initials: W
authors.lastname: Plunkett
authors.forename: A
authors.initials: A
authors.lastname: Begleiter
authors.forename: J O
authors.initials: JO
authors.lastname: Liliemark
authors.forename: J C
authors.initials: JC
authors.lastname: Reed
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use*; D017338:Cladribine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D001084:Vidarabine Phosphate; D002699:Chlorambucil; C042382:fludarabine phosphate; D017338:Cladribine